Simultaneously creating value for patients, suppliers of medicines and the healthcare system is a win/win/win proposition.
A “future proof” company is one that is able to anticipate, adapt and capitalize on emerging opportunities. It is able to prosper in a paradoxical world.
Geoff Zassenhaus talks with us about his lessons learned from establishing a Continuous Improvement culture at Novartis US Sales Operations.
With Chris Gish we explore the importance of rep engagement and a supportive operational culture to execute selling strategies effectively, and the need to align customer touch points across the organization.
Analytics in pharma plays a key role in driving commercial value.
Jeff Schnack of 3Rock Consulting shares his insights about how the commercial model in Japan is evolving given emerging regulations and market changes.
How sales force effectiveness in pharma is changing in an increasingly digital world.
How AR/VR technology can help in a healthcare setting.
How optimizing the customer experience in healthcare can drive better patient outcomes.
Implications for pharma organizations in the inevitable shift from price to value.